ProAssurance Corp (NYSE:PRA) exceeded Q4 2025 earnings and revenue estimates, driven by strong underwriting performance and significant favorable prior-year loss reserve development. The company reported $0.82 non-GAAP EPS on $269.6 million in revenue, surpassing analyst expectations. This positive performance occurred as the company progresses towards its acquisition by The Doctors Company, anticipated to close by June 30, 2026.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ProAssurance Corp (NYSE:PRA) Beats Q4 Estimates on Strong Underwriting and Favorable Reserves
ProAssurance Corp (NYSE:PRA) exceeded Q4 2025 earnings and revenue estimates, driven by strong underwriting performance and significant favorable prior-year loss reserve development. The company reported $0.82 non-GAAP EPS on $269.6 million in revenue, surpassing analyst expectations. This positive performance occurred as the company progresses towards its acquisition by The Doctors Company, anticipated to close by June 30, 2026.